Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a 13.302% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) CCCc1cc(=O)[nH]c(SCC(=O)N2CCOCC2)n1
b.) CCCCn1c(N)c(N(CCC(C)C)C(=O)c2ccc3c(c2)OCO3)c(=O)[nH]c1=O
c.) Cc1cc2c(=O)n(C)c(SCC(=O)Nc3cccc(O)c3)nc2s1
d.) O=C(NNC(=S)Nc1ccc(Cl)cc1Cl)c1ccc(N2CCOCC2)c([N+](=O)[O-])c1
e.) Cc1ccc(NC(=O)CN2C(=O)NC(Cc3ccccc3)C2=O)c(Br)c1
Answer: a. CCCc1cc(=O)[nH]c(SCC(=O)N2CCOCC2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCc1cc(=O)[nH]c(SCC(=O)N2CCOCC2)n1
CCCc1cc(=O)[nH]c(SCC(=O)N2CCOCC2)n1
2-(2-morpholin-4-yl-2-oxoethyl)sulfanyl-4-propyl-1H-pyrimidin-6-one